Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Bone Marrow Transplantation
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
October (2) 2002, Volume 30, Number 8, Pages 531-534
Table of contents    Previous  Abstract  Next   Full text  PDF
Case Report
Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation
K Umeda, S Adachi, K Watanabe, N Kimura, Y Lin and T Nakahata

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Correspondence to: K Umeda, Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

Abstract

A 1-year-old boy received a living-related liver transplantation (LRLT) from his HLA-haploidentical father to treat acute liver failure following non-A, non-B, non-C hepatitis. He subsequently developed pancytopenia and was diagnosed with aplastic anemia (AA). He was platelet transfusion dependent and developed two episodes of life-threatening intracranial hemorrhage despite immuno-suppressive therapy consisting of cyclosporin A, antithymocyte globulin, and anabolic steroids. He received combined hematopoietic stem cell transplantation (hSCT) with cord blood and bone marrow from an HLA-matched sibling. Conditioning consisted of cyclophosphamide (CY) 200 mg/kg and 7 Gy total lymphoid irradiation (TLI). Marrow engraftment was prompt and there was no significant graft-versus-host disease (GVHD).

Bone Marrow Transplantation (2002) 30, 531-534. doi:10.1038/sj.bmt.1703689

Keywords

aplastic anemia; liver transplantation; hepatitis; VOD; hematopoietic stem cell transplantation

Received 1 February 2002; accepted 26 June 2002
October (2) 2002, Volume 30, Number 8, Pages 531-534
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group